News Releases

Ludwig scientists to present advancements in immunotherapy, genomics and metastasis at 2014 AACR annual meeting

April 2, 2014, New York, NY—Ludwig Cancer Research previewed today the full scope of discoveries to be presented by Ludwig scientists at the American Association for Cancer Research (AACR) Annual Meeting next week (April 5 – 9) in San Diego, Calif. Ludwig researchers will deliver two-dozen presentations, and chair or participate in several symposia, educational sessions and meet-the-expert sessions.

“AACR is a premier forum for our researchers to exchange information with their colleagues on the molecular underpinnings of cancer, and strategies for translating such insights into new cancer therapies,” said David Lane, PhD, Scientific Director, Ludwig Institute for Cancer Research. “We look forward to the meeting. It is an opportunity to forge collaborations across institutions that are ultimately of benefit to cancer patients.”

Ludwig scientists will deliver presentations and share new data at the meeting on subjects ranging from cancer genomics to immunotherapy to the cellular and molecular biology of metastasis. Visit our website or click here for a comprehensive list of Ludwig presentations.

About Ludwig Cancer Research

Ludwig Cancer Research is an international collaborative network of acclaimed scientists with a 40-year legacy of pioneering cancer discoveries. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.


You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?